EXTRAPOLATION OF DACLATASVIR DOSING RECOMMENDATIONS FROM RITONAVIR BOOSTED PROTEASE INHIBITORSTO COBICISTAT PROTEASE INHIBITORS

被引：0
|
作者：
Gandhi, Y. [1 ]
Wang, Q. [1 ]
Li, W. [1 ]
Eley, T. [1 ]
Zheng, M. [1 ]
LaCreta, F. [1 ]
Bertz, R. [1 ]
Garimella, T. [1 ]
机构：
[1] Bristol Myers Squibb, Princeton, NJ USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2017年 / 101卷 / S1期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PII-044
引用
收藏
页码：S65 / S65
页数：1
相关论文
共 50 条
  • [1] Management of Antiretroviral Therapy with Boosted Protease Inhibitors - Darunavir/Ritonavir or Darunavir/Cobicistat
    Marin, Ruxandra-Cristina
    Behl, Tapan
    Negrut, Nicoleta
    Bungau, Simona
    BIOMEDICINES, 2021, 9 (03)
  • [2] Ritonavir-boosted protease inhibitors in HIV therapy
    Hull, Mark W.
    Montaner, Julio S. G.
    ANNALS OF MEDICINE, 2011, 43 (05) : 375 - 388
  • [3] Ritonavir-Boosted Protease Inhibitors but Not Cobicistat Appear Safe in HIV-Positive Patients Ingesting Dabigatran
    Kakadiya, Payal P.
    Higginson, Robert T.
    Fulco, Patricia Pecora
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (02)
  • [4] Why do people switch away from cobicistat-boosted protease inhibitors?
    Byrne, L.
    Kabagambe, S.
    Awosusi, F.
    Sarner, L.
    HIV MEDICINE, 2018, 19 : S33 - S33
  • [5] Predictors of virologic response to ritonavir-boosted protease inhibitors
    Marcelin, AG
    Flandre, P
    Peytavin, G
    Calvez, V
    AIDS REVIEWS, 2005, 7 (04) : 225 - 232
  • [6] Darunavir/cobicistat as antiretroviral treatment simplification strategy in patients with stable monotherapy with ritonavir-boosted protease inhibitors in the clinical setting
    Ramon Santos, Jose
    Pelaez Ibanez, Pablo
    Bravo, Isabel
    Maria Llibre, Josep
    Paredes, Roger
    Clotet, Bonaventura
    Molto, Jose
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2016, 19
  • [7] Delavirdine increases drug exposure of ritonavir-boosted protease inhibitors
    Harris, M
    Alexander, C
    O'Shaughnessy, M
    Montaner, JSG
    AIDS, 2002, 16 (05) : 798 - 799
  • [8] HIV monotherapy with ritonavir-boosted protease inhibitors: a systematic review
    Bierman, Wouter F. W.
    van Agtmael, Michiel A.
    Nijhuis, Monique
    Danner, Sven A.
    Boucher, Charles A. B.
    AIDS, 2009, 23 (03) : 279 - 291
  • [9] Ritonavir-boosted protease inhibitors: Impact of ritonavir on toxicities in treatment-experienced patients
    Sension, Michael
    Piliero, Peter J.
    JANAC-JOURNAL OF THE ASSOCIATION OF NURSES IN AIDS CARE, 2007, 18 (01): : 36 - 47
  • [10] Tipranavir: A ritonavir-boosted protease inhibitor
    Hicks, C
    DRUGS, 2005, 65 (12) : 1678 - 1678
12345